Crossmark

Electronic adaptation and danish cross-cultural translation of PEmb-QoL and VEINES-QoL/Sym for patients with venous thromboembolism

Crossref DOI link: https://doi.org/10.1186/s41687-024-00698-9

Published Online: 2024-02-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lindegaard, Stine Foged

Højen, Anette Arbjerg

Rolving, Nanna http://orcid.org/0000-0001-9195-7278
Funding

Funding for this research was provided by:

The Danish Heart Foundation (21-R153-A9878-22185)

Novo Nordisk Fonden (NNF21OC0072631)
License Information

Text and Data Mining valid from 2024-02-26

Version of Record valid from 2024-02-26
More Information

Article History

Received: 13 June 2023

Accepted: 7 February 2024

First Online: 26 February 2024

Declarations

:

: In accordance with Danish law, interview studies do not require approval from a Health Research Ethics Committee (the Act on Research Ethics Review of Health Research Projects (§ 14, subsection 2)). The patients all signed a written consent before entering the study and were informed that their consent could be withdrawn at any time point and without consequences.

: Consent to publish was obtained from all participants.

: AAH has received research grants from The Danish Heart Foundation and The Novo Nordisk Foundation, consulting fees from Bayer and The Bristol-Myers Squibb-Pfizer Alliance, and speaker bureaus from Bayer, The Bristol-Myers Squibb-Pfizer Alliance. NR has given talks about PE and physical rehabilitation on postgraduate courses for nurses and physicians within thrombosis and participated in development and production of patient information material on the same subject, both sponsored by Bayer and Bristol-Myers Squibb-Pfizer Alliance. SFL has no conflicts of interest to declare. Deep vein thrombosis.

Document is current

Any future updates will be listed below